EUVIMEDEUVIMED entdecken
Open Access

Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells

Kelly McCastlain iD, Catherine Welsh iD, Yonghui Ni iD, Liang Ding, Ti-Cheng Chang iD, Robert J Autry iD, Besian I Sejdiu iD, Qingfei Pan iD, Melissa Franco iD, Wenan Chen iD, Huiyun Wu iD, Veronica Gonzalez-Pena iD und 13 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adt3873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Kelly McCastlain und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell & Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mutation, Leukemia, Heteroplasmy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Somatic mitochondrial DNA (mtDNA) mutations are frequently observed in tumors, yet their role in pediatric cancers remains poorly understood. The heteroplasmic nature of mtDNA—where mutant and wild-type mtDNA coexist—complicates efforts to define its contribution to disease progression. In this study, bulk whole-genome sequencing of 637 matched tumor-normal samples from the Pediatric Cancer Genome Project revealed an enrichment of functionally impactful mtDNA variants in specific pediatric leukemia subtypes. Collectively, the results from single-cell sequencing of five diagnostic leukemia samples demonstrated that somatic mtDNA mutations can arise early in leukemogenesis and undergo positive selection during disease progression, achieving intermediate heteroplasmy—a “sweet spot” that balances mitochondrial dysfunction with cellular fitness. Network-based systems biology analyses link specific heteroplasmic mtDNA mutations to metabolic reprogramming and therapy resistance. We reveal somatic mtDNA mutations as a potential source of functional heterogeneity and cellular diversity among leukemic cells, influencing their fitness and shaping disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, MitochondrialMutationLeukemiaHeteroplasmyGenetic HeterogeneityHumansSingle-Cell AnalysisChildMitochondriaWhole Genome Sequencing

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Department of Cell & Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Mathematics & Computer Science, Rhodes College, Memphis, TN, USA.
  • Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.

ORCID-Profile: Kelly McCastlain, Catherine Welsh, Yonghui Ni, Ti-Cheng Chang, Robert J Autry, Besian I Sejdiu, Qingfei Pan, Melissa Franco, Wenan Chen, Huiyun Wu, Veronica Gonzalez-Pena, Patrick Schreiner, Joung Hyuck Joo, Samuel Brady, Jinghui Zhang, Charles Gawad, William E Evans, M Madan Babu, Jiyang Yu, Gang Wu, Stanley Pounds, Mondira Kundu

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

McCastlain, K., Welsh, C., Ni, Y., Ding, L., Chang, T. C., Autry, R. J., Sejdiu, B. I., Pan, Q., Franco, M., Chen, W., Wu, H., Gonzalez-Pena, V., Schreiner, P., Arunachalam, S., Joo, J. H., Brady, S., Zhang, J., Gawad, C., Evans, W. E., …, & Kundu, M. (2025). Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells. Science Advances. https://doi.org/10.1126/sciadv.adt3873

Vancouver

McCastlain K, Welsh C, Ni Y, Ding L, Chang TC, Autry RJ, et al. Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells. Science Advances. 2025. doi:10.1126/sciadv.adt3873

BibTeX
@article{McCastlain2025,
  author = {McCastlain, Kelly and Welsh, Catherine and Ni, Yonghui and Ding, Liang and Chang, Ti-Cheng and Autry, Robert J and Sejdiu, Besian I and Pan, Qingfei and Franco, Melissa and Chen, Wenan and Wu, Huiyun and Gonzalez-Pena, Veronica and Schreiner, Patrick and Arunachalam, Sasi and Joo, Joung Hyuck and Brady, Samuel and Zhang, Jinghui and Gawad, Charles and Evans, William E and Babu, M Madan and Khrapko, Konstantin and Yu, Jiyang and Wu, Gang and Pounds, Stanley and Kundu, Mondira},
  title = {Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adt3873}
}
Kostenlos starten →